Mesenchymal Stem cells (MSCs) are stromal cells that have the ability to self-renew and also exhibit multilineage differentiation. It can be isolated from a variety of tissues, such as the umbilical cord, endometrial polyps, menses blood, bone marrow, adipose tissue, etc. It is most preferred cell type for regenerative medicine that used to treat neurological disorders, cardiac ischemia, diabetes, and bone and cartilage diseases.
MARKET SCOPE
The "Global Mesenchymal Stem Cells Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Mesenchymal Stem Cells market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading Mesenchymal Stem Cells market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type the market is segmented as, Autologous and Allogeneic.
- Based on source the market is segmented as, Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal liver, Lung, and Adipose tissues
- Based on indication the market is segmented as, Bone and cartilage repair, Cardiovascular disease, Inflammatory & immunological diseases, Liver diseases, Cancer, GvHD, and Others
- Based on application the market is segmented as, Disease modeling, Drug development & discovery, Stem cell banking, Tissue engineering, Toxicology studies, and Others
MARKET DYNAMICS
Drivers:
- Rising prevalence of cancer, neurological disorders, cardiac ischemia, diabetes, and bone and cartilage diseases.
- Approval from regulatory bodies to make the mesenchymal stem cell use.
- Rising number of clinical trials.
Restraints:
- Whereas, high cost of treatment is expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Mesenchymal Stem Cells market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social and technological factors affecting the Mesenchymal Stem Cells market in these regions.
IMPACT OF COVID-19 ON MESENCHYMAL STEM CELLS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Mesenchymal Stem Cells market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Mesenchymal Stem Cells market are anticipated to lucrative growth opportunities in the future with the rising demand for Mesenchymal Stem Cells in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Mesenchymal Stem Cells market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- CELL APPLICATIONS, INC.
- AXOL BIOSCIENCES LTD.
- CYTORI THERAPEUTICS INC
- STEMCELL TECHNOLOGIES INC
- CYAGEN BIOSCIENCES INC.
- CELPROGEN INC
- BRAINSTORM CELL THERAPEUTICS INC.
- STEMEDICA CELL TECHNOLOGIES INC
- MERCK KGAA (MILLIPORESIGMA)
- SMITH AND NEPHEW
- LONZA AG
- PROMOCELL GMBH
- THERMO FISHER SCIENTIFIC